Risk factors for neurological complications in children with Flavivirus infection

Aline Almeida Bentes1,2, Roberta Maia de Castro Romanelli1, Paula Eillanny Silva Marinho3

  • 1Departamento de Pediatria, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Insights

This study on dengue, Zika, and yellow fever viruses in children found no difference in neurological complication recovery times. However, Yellow Fever Virus (YFV) infection increased the risk of developing these complications.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pediatrics

Background:

  • Dengue virus (DENV), Zika virus (ZIKV), and Yellow Fever Virus (YFV) are flaviviruses that can cause central nervous system (CNS) infections.
  • Neurological manifestations in children require thorough characterization and risk factor identification for effective management.

Purpose of the Study:

  • To characterize acute neurological manifestations of DENV, ZIKV, and YFV in hospitalized children.
  • To identify risk factors for persistent neurological complications post-discharge.
  • To evaluate the time to neurological complication resolution.

Main Methods:

  • A prospective study of 505 children hospitalized with suspected CNS infections between March 2014 and July 2019.
  • Real-time reverse transcription-polymerase chain reaction (RT-PCR) used to confirm viral RNA in cerebrospinal fluid (CSF).
  • Clinical follow-up, predictive factor analysis, and survival curves were employed.

Main Results:

  • Clinical symptoms, CSF analysis, EEG, and CNS imaging predicted complications in children with DENV, ZIKV, or YFV CNS infections.
  • No significant difference in complication resolution time was observed among the three flaviviruses (p=0.574).
  • Children with YFV showed a 53% higher risk of developing neurological complications.

Conclusions:

  • Early etiological diagnosis via RT-PCR in CSF is crucial for managing pediatric flavivirus CNS infections.
  • Identifying predictors of complications aids in improving prognosis and clinical follow-up.
  • While recovery times are similar, YFV poses a greater risk for neurological complications.